๐ฐ Time Data Services News
Page 2 - Time Data Services News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Time Data Services. Real-time updates on events, politics, business and more.
May 2, 2022
SK bioscience and GSK have reported that their Covid-19 vaccine candidate, SKYCovione met the coprimary goals in the Phase III clinical trial.
April 28, 2022
The UT Health San Antonio has received a four-year award of $2.4m from the NIH to study usage of antibiotics for periodontal disease.
April 26, 2022
Priothera has announced plans to commence Phase IIb/III trial of mocravimod in acute myeloid leukaemia patients undergoing allogeneic HSCT.
April 26, 2022
Covid-19 restrictions resulted in behavioural changes that affected the transmission of other infectious diseases, including dengue virus.
April 22, 2022
The FSHD Society is set to improve clinical trial design for facioscapulohumeral muscular dystrophy by deploying AI technology.
April 11, 2022
Gannex Pharma has dosed the first subject in Phase II trial of ASC42 for the treatment of primary biliary cholangitis (PBC) patients.
April 8, 2022
Clinical Trials Arena looks at a potential shake-up in alopecia areata's treatment paradigm and an emerging treatment mechanism.
April 7, 2022
The Canadian Cancer Trials Group (CCTG) has obtained a grant of $30m from CCS to guarantee continued access to impactful clinical trials.
April 7, 2022
Eucure Biopharma has dosed the first subject in Phase I trial of its YH003 along with YH001 and pembrolizumab for solid tumour in Australia.
March 24, 2022
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataรขยยs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A sma...